🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Central retinal vein occlusion (CRVO) is a common retinal vascular disorder...
Status
Completed
Location
Multiple Locations
Start Date
2017-01-01
Trial ID
NCT06416241
Treatments Being Tested
The goal of this observational clinical study is to collect more informatio...
Status
Not Yet Recruiting
Location
Espaço Médico de Coimbra, Lda.
Start Date
2026-05
Trial ID
NCT07340372
Treatments Being Tested
This is a randomized, double-masked, multicenter study to evaluate the effi...
Status
Completed
Location
Research Site
Start Date
2020-07-21
Trial ID
NCT04522167
Treatments Being Tested
EYE-RES-104 is a randomized, dose-masked study of intravitreal EYE103 in pa...
Status
Recruiting
Location
Scottsdale, Arizona
Start Date
2025-09-12
Trial ID
NCT07205887
Treatments Being Tested
The purpose of this clinical study is to evaluate the efficacy and safety o...
Status
Terminated
Location
Kanghong Investigative Site
Start Date
2018-09-25
Trial ID
NCT03577899
This is a Phase III, multicenter, randomized, double-masked, active compara...
Status
Completed
Location
Barnet Dulaney Perkins Eye Center
Start Date
2021-03-02
Trial ID
NCT04740931
Treatments Being Tested
The purpose of the present study was to evaluate the outcomes of type 1 mac...
Status
Completed
Location
Jae Hui Kim
Start Date
2022-12-05
Trial ID
NCT05662943
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of single ...
Status
Completed
Location
Retinal Consultants of Arizona
Start Date
2017-08-29
Trial ID
NCT03249740
Treatments Being Tested
Goals of the study are to evaluate how peri-operative versus intra-operativ...
Status
Withdrawn
Location
Emory Clinic
Start Date
2020-05
Trial ID
NCT03920878
Treatments Being Tested
Study purpose: To evaluate if previously high-frequent (3-5 weekly) afliber...
Status
Completed
Location
Department of Ophthalmolgy, Medical University Graz
Start Date
2023-07-04
Trial ID
NCT05941715
Treatments Being Tested